Zenas BioPharma (ZBIO) Amortizatization of Intangibles (2025 - 2026)
Zenas BioPharma's (ZBIO) quarterly Amortizatization of Intangibles came in at -$110000.0 in Q1 2026, up 71.2% year-on-year from -$64250.8 in Q1 2025, and up 73.87% quarter-over-quarter from -$421000.0 in Q4 2025.
Zenas BioPharma (ZBIO) Amortizatization of Intangibles (2025 - 2026) Analysis & Trends
Zenas BioPharma's Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at -$110000.0 for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 71.2% year-over-year to -$110000.0 in Q1 2026; TTM through Mar 2026 was -$1.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$1.9 million, down 220.76% from the prior year.
- Amortizatization of Intangibles climbed to -$110000.0 in Q1 2026 per ZBIO's latest filing, from -$421000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at -$110000.0 in Q1 2026 and bottomed at -$935000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Zenas BioPharma | 1.82 Bn | 1.10 Bn | - | -110,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -110,000.00 |
| Mar 31, 2026 | -110,000.00 |
| Dec 31, 2025 | -421,000.00 |
| Dec 31, 2025 | -421,000.00 |
| Sep 30, 2025 | -193,000.00 |
| Sep 30, 2025 | -193,000.00 |
| Jun 30, 2025 | -935,000.00 |
| Jun 30, 2025 | -935,000.00 |
| Mar 31, 2025 | -382,000.00 |
| Mar 31, 2025 | -382,000.00 |